Zobrazeno 1 - 10
of 22
pro vyhledávání: '"DESPINA MOURATIDOU"'
Autor:
Vasilis Kouloulias, Dionysios Voros, Despina Mouratidou, Constantine Gennatas, Nikolaos Tsavaris, Nikiforita Poulakaki, J. Psychogios, Vasiliki Michalaki, George Katsiamis, Eleni Carvounis
Publikováno v:
Scopus-Elsevier
Aims and Background The understanding of hormonal therapies in postmenopausal women with metastatic breast cancer has advanced greatly in the past several decades. With the introduction of orally active, potent and selective third-generation aromatas
Autor:
Fotini Christidou, Leora Moldovan, Charalampos Andreadis, Christos Zavos, Despina Mouratidou, Dimitrios Platogiannis, Theodoros Bischiniotis
Publikováno v:
Melanoma Research. 15:441-446
Although malignant melanoma has a great propensity (38-50%) for cardiac involvement, as indicated by autopsy findings, cardiac metastases are rarely identified ante-mortem. The aim of this study was to record abnormal electrocardiographic and echocar
Autor:
Despina Mouratidou, Charalampos Andreadis, Nikolaos Diamantopoulos, Martha Charalampidou, Nikolaos Chouchos
Publikováno v:
Gynecologic Oncology. 95:252-255
A 33-year-old woman with T(4c)N(3) breast cancer with metastases in the skeleton (M(1)) received five cycles of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC regimen) before conception and during the first trimester. Salvage radiotherapy (28
Autor:
Efstathios Papalambros, Helias Margaris, G Karatzas, Evanthia Tzima, Kostadinos Gennatas, George Papastratis, Christos Kosmas, Despina Mouratidou, Aris Polyzos, N. Tsavaris, Nikitas Papadoniou, Panagiotis Gouveris, Heracles Tsipras
Publikováno v:
Investigational New Drugs. 22:193-198
Objectives: To evaluate the efficacy and safety of weekly administration of gemcitabine treatment in chemotherapy-naive patients with advanced biliary tract and gallbladder cancer. Patients and methods: Gemcitabine at a dose of 800 mg/m2 was administ
Publikováno v:
Medical Hypotheses. 63:511-514
It has already been established that the growth effects of growth hormone (GH) are mediated through insulin-like growth factor I (IGF-I). Recent studies demonstrated a relationship between IGF-I levels and various types of cancer, namely colon, prost
Autor:
Despina Mouratidou, Georgios Skaragkas, Christos Manes, Helias Iliades, Efthymios Kapantais, Eftychia Chala
Publikováno v:
Hormones (Athens, Greece). 5(2)
OBJECTIVE: To evaluate insulin values, insulin resistance, growth factors and cytokine levels in women suffering from breast cancer and the effect of chemotherapy on these parameters. DESIGN: In a prospective study, glucose and insulin values were de
Autor:
Constantine, Gennatas, Vasiliki, Michalaki, Despina, Mouratidou, Nikolaos, Tsavaris, Charalambos, Andreadis, John, Psychogios, Nikiforita, Poulakaki
Publikováno v:
Anticancer research. 26(1B)
To evaluate the activity and toxicity of gemcitabine and vinorelbine in patients with metastatic breast cancer (MBC), previously treated with anthracyclines alone or with taxanes.A total of 86 pretreated patients with MBC (median age 62 years), enter
Breast metastases from gastric cancer are extremely rare. A case report of a 37-year-old female with breast inflammatory invasion and ascites is described. Breast biopsy revealed carcinomatous invasion of the lymphatics from adenocarcinoma cells with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::287436094ca65b2b85833e4d5ac07211
https://europepmc.org/articles/PMC4087820/
https://europepmc.org/articles/PMC4087820/
Autor:
Constantine, Gennatas, Vasiliki, Michalaki, Despina, Mouratidou, Nikolaos, Tsavaris, Charalambos, Andreadis, Alexios, Photopoulos, Dionysios, Voros
Publikováno v:
In vivo (Athens, Greece). 20(2)
Gemcitabine is an active agent in pancreatic cancer, showing clinical synergy with 5-fluorouracil (5-FU). The aim of the study was to evaluate the safety and efficacy of the combination of gemcitabine and 5-FU in patients with advanced adenocarcinoma
Autor:
Alexandros H. Kortsaris, Grammati Galaktidou, Stavros Touloupidis, Anastasios Boutis, Charalampos Andreadis, Despina Mouratidou
Publikováno v:
The Journal of urology. 174(5)
Previous studies have shown that serum levels of the degradation products of cytokeratins could be used as surrogate markers in the diagnosis and followup of patients with solid tumors, including tumors of the bladder.The soluble cytokeratin 19 fragm